The results presented in this paper indicate that due to the balanced anti-inflammatory properties, resulting mainly from PDE7A and, to a lesser extent, PDE4B inhibition, GRMS-55 exhibited high hepatoprotective activity in mice with ConA-induced hepatitis. The gene discussed is PDE4B; the disease is hepatitis A virus infection.